BVXP Stock Overview
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Bioventix PLC Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£41.75 |
52 Week High | UK£51.00 |
52 Week Low | UK£34.02 |
Beta | 0.35 |
11 Month Change | -3.47% |
3 Month Change | -9.24% |
1 Year Change | 8.44% |
33 Year Change | 4.90% |
5 Year Change | 11.33% |
Change since IPO | 2,041.03% |
Recent News & Updates
Estimating The Fair Value Of Bioventix PLC (LON:BVXP)
Jun 19Bioventix's (LON:BVXP) Dividend Will Be £0.68
Mar 29We Think Shareholders May Consider Being More Generous With Bioventix PLC's (LON:BVXP) CEO Compensation Package
Dec 01Recent updates
Estimating The Fair Value Of Bioventix PLC (LON:BVXP)
Jun 19Bioventix's (LON:BVXP) Dividend Will Be £0.68
Mar 29We Think Shareholders May Consider Being More Generous With Bioventix PLC's (LON:BVXP) CEO Compensation Package
Dec 01Bioventix (LON:BVXP) Is Increasing Its Dividend To £0.62
Mar 30Bioventix (LON:BVXP) Is Increasing Its Dividend To UK£0.52
Mar 31Should Bioventix PLC (LON:BVXP) Be Part Of Your Dividend Portfolio?
Mar 29Is Now The Time To Put Bioventix (LON:BVXP) On Your Watchlist?
Mar 14What Does Bioventix's (LON:BVXP) CEO Pay Reveal?
Feb 27Shareholders of Bioventix (LON:BVXP) Must Be Delighted With Their 364% Total Return
Jan 31Is Bioventix PLC (LON:BVXP) Popular Amongst Insiders?
Jan 18Is Bioventix PLC's (LON:BVXP) Latest Stock Performance Being Led By Its Strong Fundamentals?
Jan 06Here's How We Evaluate Bioventix PLC's (LON:BVXP) Dividend
Dec 23Does Bioventix's (LON:BVXP) CEO Salary Compare Well With Industry Peers?
Nov 28Shareholder Returns
BVXP | GB Biotechs | GB Market | |
---|---|---|---|
7D | 0.6% | -7.6% | -1.2% |
1Y | 8.4% | -28.6% | 4.4% |
Return vs Industry: BVXP exceeded the UK Biotechs industry which returned -27.1% over the past year.
Return vs Market: BVXP exceeded the UK Market which returned 5.4% over the past year.
Price Volatility
BVXP volatility | |
---|---|
BVXP Average Weekly Movement | 2.9% |
Biotechs Industry Average Movement | 7.0% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.7% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: BVXP has not had significant price volatility in the past 3 months.
Volatility Over Time: BVXP's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 12 | Peter Harrison | www.bioventix.com |
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services.
Bioventix PLC Fundamentals Summary
BVXP fundamental statistics | |
---|---|
Market cap | UK£216.62m |
Earnings (TTM) | UK£8.67m |
Revenue (TTM) | UK£13.60m |
25.1x
P/E Ratio16.0x
P/S RatioIs BVXP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BVXP income statement (TTM) | |
---|---|
Revenue | UK£13.60m |
Cost of Revenue | UK£850.45k |
Gross Profit | UK£12.75m |
Other Expenses | UK£4.08m |
Earnings | UK£8.67m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.66 |
Gross Margin | 93.75% |
Net Profit Margin | 63.73% |
Debt/Equity Ratio | 0% |
How did BVXP perform over the long term?
See historical performance and comparison